Expression profiling of esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: Clinical implications

International Journal of Oncology

Volumn 28, Issue 6, 2006, Pages 1345-1352

  Ashida, Akio ^a   Boku, Narikazu ^b   Aoyagi, Kazuhiko ^a   Sato, Hiroshi ^a   Tsubosa, Yasuhiro ^a   Minashi, Keiko ^b   Muto, Manabu ^b   Ohtsu, Atsushi ^b   Ochiai, Atsushi ^b   Yoshida, Teruhiko ^a   Yoshida, Shigeaki ^b   Sasaki, Hiroki ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b National Cancer Center   (Japan)

Author keywords

Chemoradiotherapy; Esophageal cancer; Microarray; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; RNA;

ADULT; AGED; ARTICLE; ESOPHAGUS TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; RNA, NEOPLASM; TREATMENT OUTCOME;

EID: 33747087344     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.6.1345     Document Type: Article

References (19)

1. Roth JA and Putnam JB Jr: Surgery for cancer of the esophagus. Semin Oncol 21: 453-461, 1994.
2. Akiyama H, Tsurumaru M, Udagawa H and Kajiyama Y: Radical lymph node dissection for cancer of the thoracic esophagus. Ann Sug 220: 364-373, 1994. (Pubitemid 24313229)
3. Baba M, Aikou T, Yoshinaga H, Natsugoe S, Fukumoto T, Shimazu H and Akazawa K: Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Sug 219: 310-316, 1994.
4. Ando N, Iizuka T, Kakegawa T, Isono K, Watanabe H, Ide H, Tanaka O, Shinoda M, Takiyama W, Arimori M, Ishida K and Tsugane S: A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 114: 205-209, 1997.
5. Scanlon KJ, Newman YL and Priest DG: Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 83: 8923-8925, 1986.
6. Byfield JE: Combined modality infusional chemotherapy with radiation. In: Cancer Chemotherapy by Infusion. 2nd edition. Lokich JJ (ed). Percepta Press, Chicago, pp521-551, 1990.
7. Douple EB and Richmond RC: A review of interactions between platinum coordination complexes and ionizing radiation: implication for cancer therapy. In: Cisplatin: Current Status and New Developments. Prestayko AW, Crook ST and Karter SK (eds). Academic, Orlando, pp125-147, 1980.
8. Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, Seki S, Kaneko K and Nakamura A: Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17: l2915-12921, 1999.
9. Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, Muto M, Ogino T and Yoshida S: Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21: 2697-2702, 2003. (Pubitemid 46606313)
10. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, Cooper J, Byhardt R, Davis L and Emami B: Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15: 277-284, 1997. (Pubitemid 27020584)
11. Eisen MB, Spellman PT, Brown PO and Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868, 1998.
12. Yasui K, Imoto I, Fukuda Y, Pimkhaokham A, Yang ZO, Naruto T, Shimada Y, Nakamura Y and Inazawa J: Identification of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma. Genes Chromosome Cancer 32: 112-118, 2001.
13. Suit HD and Suchato C: Hyperbaric oxygen and radiotherapy of a fibrosarcoma and of a squamous-cell carcinoma of C3H mice. Radiology 89: 713-719, 1967.
14. Moulder JE and Rockwell S: Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev 5: 313-341, 1987.
15. Rockwell S and Moulder JE: Hypoxic fractions of human tumors xenografted into mice: a review. Int J Radiat Oncol Biol Physiol 19: 197-202, 1990.
16. Kamijo T, Yokose T, Hasebe T, Yonou H, Sasaki S, Hayashi R, Ebihara S, Miyahara H, Hosoi H and Ochiai A: Potential role of microvessel density in predicting radiosensitivity of T1 and T2 stage laryngeal squamous cell carcinoma treated with radiotherapy. Clin Cancer Res 6: 3159-3165, 2000.
17. Hironaga S, Hasebe T, Kamijo T, Ohtsu A, Boku N, Yoshida S, Saitoh H and Ochiai A: Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy. Clin Cancer Res 8: 124-130, 2002.
18. Chakraborty M, Abrams SI, Champhausen K, Liu K, Scott T, Coleman CN and Hodge JW: Irradiation of tumor cells upregulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J Immunol 170: 6338-6347, 2003.
19. Charlie TG, Claudia P, Mala C, Kwong-Yok T, Jeffrey S and James WH: Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res 64: 7985-7994, 2004.